Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. (2023)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.00969-2023
PubMed Identifier: 37945035
Publication URI: http://europepmc.org/abstract/MED/37945035
Type: Journal Article/Review
Volume: 62
Parent Publication: The European respiratory journal
Issue: 5
ISSN: 0903-1936